Sinonasal malignancies make up <5% of all head and neck neoplasms, with an incidence
of 0.5–1.0 per 100,000. The outcome of these rare malignancies has been poor, whereas …

Importance Management of cervical unknown primary squamous cell carcinoma (CUP) has
evolved with the introduction of transoral robotic surgery (TORS). Objectives 1. To describe …

Importance Current olfactory neuroblastoma (ONB) staging systems inadequately delineate
locally advanced tumors, do not incorporate tumor grade, and poorly estimate survival and …

Background Sinonasal squamous cell carcinoma (SNSCC) is a rare malignancy that poses
management challenges. Although surgery and chemoradiation therapy (CRT) remain …

Background Quality of life (QOL) for individuals with sinonasal malignancy (SNM) is significantly
under‐studied, yet it is critical for counseling and may impact treatment. In this study we …

Simple Summary Sinonasal malignancies are aggressive tumors that can be exceptionally
difficult to treat. Surgery and adjuvant radiation therapy is considered first line therapy for both …

Background Sinonasal neoplasms, whether benign and malignant, pose a significant
challenge to clinicians and represent a model area for multidisciplinary collaboration in order to …

Background The impact of sinonasal malignancies (SNMs) on quality of life (QOL) at
presentation is poorly understood. The Sinonasal Outcome Test (SNOT‐22) and University of …

Importance The American Joint Committee on Cancer, 8th edition (AJCC-8) contains a new
staging system for human papillomavirus (HPV)-related oropharyngeal squamous cell …

Importance Transoral robotic surgery (TORS) is increasingly employed as a treatment option
for squamous cell carcinoma of the oropharynx (OPSCC). Measures of surgical learning …